Moderate-Large Ketonuria in Non-Diabetic AKI: Stress-Induced Ketosis from Severe Illness
In your non-diabetic patient with AKI, severe hypertension, and complement-mediated TMA who is eating normally with normal glucose, the moderate-large ketonuria most likely represents stress-induced ketosis from the severe metabolic stress of acute kidney injury and critical illness, not a primary metabolic disorder.
Understanding the Mechanism
The ketone bodies (acetoacetate, β-hydroxybutyrate, and acetone) are catabolic products of free fatty acids that normally exist in very low concentrations (<0.5 mmol/L) 1. Your patient's ketonuria reflects increased counterregulatory hormone release (cortisol, epinephrine, glucagon, growth hormone) triggered by the severe physiologic stress of AKI and TMA 1.
Key Pathophysiologic Points:
- Stress hormones drive lipolysis and ketogenesis even without insulin deficiency or starvation 1
- The equilibrium shifts toward β-hydroxybutyrate production in conditions that alter hepatic mitochondrial redox state, including hypoxia and metabolic disorders 1
- Acute kidney injury itself creates a profoundly catabolic state that promotes ketone production 2
Why This Makes Sense in Your Patient
Your clinical scenario fits a pattern of overlapping metabolic stressors 2:
- Severe AKI (likely from TMA) creates massive metabolic stress
- Severe hypertension compounds endothelial injury and tissue hypoxia
- Complement-mediated TMA causes widespread microvascular damage and organ dysfunction 3, 4
Even though the patient is eating normally, the severe illness state overrides normal metabolic regulation. This is analogous to euglycemic ketoacidosis where multiple mechanisms coexist 2.
Critical Differential Considerations
What This Is NOT (based on your clinical picture):
- Not DKA: Normal glucose, no diabetes, no glucosuria rules this out 1
- Not starvation ketosis alone: Patient eating normally
- Not alcoholic ketoacidosis: No mention of alcohol use
- Not medication-induced: You've excluded SGLT2 inhibitors and other culprits
What This COULD Be:
Most likely: Stress ketosis from severe AKI/TMA - The profound metabolic derangement from acute kidney injury (eGFR dropping precipitously) combined with TMA-induced tissue hypoxia creates the perfect storm for ketogenesis 2.
Clinical Significance and Management Approach
The ketonuria itself is not the primary problem—it's a marker of severe metabolic stress from the underlying AKI and TMA 2. Your management should focus on:
Immediate Priorities:
- Treat the underlying TMA aggressively - Consider complement blockade (eculizumab/ravulizumab/crovalimab) if complement-mediated mechanism confirmed 3, 5, 4
- Support kidney function - The AKI is driving the metabolic derangement
- Control severe hypertension - Reduces ongoing endothelial injury
- Ensure adequate caloric intake - Even though eating, may need supplementation given catabolic state
Monitoring Strategy:
- Serial ketone measurements are NOT clinically useful here 6 - Focus on kidney function, hemolysis markers, and platelet counts instead
- The ketonuria should resolve as the AKI improves and metabolic stress diminishes 2
- If ketones persist despite improving kidney function, reassess for other causes
Important Caveats
Do not be distracted by the ketonuria - In hospitalized non-diabetic patients, ketonuria is surprisingly common (26% in one study) and often reflects relative insulinopenia from stress rather than a primary ketotic disorder 6. The study found that in most cases, no diagnostic test or therapy change was ordered specifically because of ketonuria 6.
The pattern of rapid improvement with targeted treatment of the underlying cause (AKI/TMA) rather than ketone-directed therapy confirms this is secondary stress ketosis 2. One case report demonstrated remarkable improvement within 48 hours when treating the overlapping causes of metabolic acidosis rather than focusing on ketones alone 2.
Bottom Line
Your patient's ketonuria is a metabolic epiphenomenon of severe illness (AKI + TMA + severe hypertension), not a primary disorder requiring specific ketone-directed treatment. Focus your therapeutic efforts on the complement-mediated TMA and supporting kidney function—the ketones will resolve as the patient recovers 3, 2, 4.